There are six standing committees of the Johnson & Johnson Board of Directors:

• Audit Committee
• Compensation & Benefits Committee
• Nominating & Corporate Governance Committee
• Finance Committee
• Regulatory, Compliance & Government Affairs Committee
• Science & Technology Committee

See the descriptions provided below for each committee. For the charter and membership of the Audit, Compensation & Benefits, Nominating & Corporate Governance, Regulatory, Compliance & Government Affairs and Science & Technology Committees, please click on the respective heading.

To learn how the Johnson & Johnson Board of Directors make up each committee, please see the Board Committee Chart.

Audit Committee: composed of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

• Helps the Board oversee the Company's accounting and reporting practices.
• Appoints the independent public auditor and reviews its performance.
• Monitors adequacy of internal accounting practices, procedures and controls.
• Reviews the Company's financial reporting process and disclosure procedures.

Compensation & Benefits Committee: composed of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

• Establishes the Company's executive compensation philosophy and principles, reviews and recommends for approval by the Board the compensation for the Chief Executive Officer and non-employee directors, and approves the compensation for the Company's other executive officers.
• Reviews the philosophy and policies of the non-Board Management Compensation Committee with respect to management compensation, perquisites and other compensation policies for non-executive employees.
• Oversees the management of the various retirement, pension, long-term incentive, savings, and health and welfare plans that cover the Company's employees.

Finance Committee: composed of the Chairman and Presiding Director of the Board, exercises the authority of the Board during the intervals between Board meetings.

Nominating & Corporate Governance Committee: composed of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

• Oversees corporate governance matters.
• Reviews possible candidates for Board membership and recommends nominees for election.
• Oversees the process for performance evaluations of the Board and its committees.
• Reviews the Company's executive succession plans and executive resources.

Regulatory, Compliance & Government Affairs Committee: composed of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange:

• Oversees the Company's non-financial compliance programs and systems with respect to legal and regulatory requirements.
• Oversees compliance with any ongoing Corporate Integrity Agreements or any similar undertakings by the Company with a government agency.
• Reviews the organization, implementation and effectiveness of the Company's health care compliance & ethics and quality & compliance programs.
• Oversees the Company's Policy on Business Conduct and Code of Business Conduct & Ethics for Members of the Board of Directors and Executive Officers.
• Reviews the Company's governmental affairs policies and priorities and other public policy issues facing the Company.
• Reviews the policies, practices and priorities for the Company's political expenditure and lobbying activities.

Science & Technology Committee: composed of non-employee Directors, determined to be "independent" under the listing standards of the New York Stock Exchange.

• Helps the Board with scientific matters impacting the Company's business, including monitoring the strategy and effectiveness of the Company's research and development organization.
• Reviews the effectiveness of scientific aspects of the Company's product safety processes.
• Reviews the Company's policies, programs and practices on environment, health, safety and sustainability.
• Identifies and understands significant new science and technology policy issues and trends.
• Oversees major business development activities related to the acquisition of new science or technology.

Our Management Approach